156 related articles for article (PubMed ID: 36811696)
1. The Novel 5-Fluorouracil Loaded Ruthenium-based Nanocarriers Enhanced Anticancer and Apoptotic Efficiency while Reducing Multidrug Resistance in Colorectal Cancer Cells.
Danişman-Kalindemirtaş F; Özerkan D; Kariper İA; Bulut H
J Fluoresc; 2023 May; 33(3):1227-1236. PubMed ID: 36811696
[TBL] [Abstract][Full Text] [Related]
2. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
Smith T; Affram K; Nottingham EL; Han B; Amissah F; Krishnan S; Trevino J; Agyare E
Sci Rep; 2020 Oct; 10(1):16989. PubMed ID: 33046724
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of kaempferol and 5‑fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway.
Li Q; Wei L; Lin S; Chen Y; Lin J; Peng J
Mol Med Rep; 2019 Jul; 20(1):728-734. PubMed ID: 31180555
[TBL] [Abstract][Full Text] [Related]
4. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.
Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M
Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689
[TBL] [Abstract][Full Text] [Related]
6. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
7. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
8. Design of novel polyurethane-based ionene nanocarriers for cancer therapy: Synthesis, in-vitro, and in-vivo studies.
Mahdieh A; Yeganeh H; Sande SA; Nyström B
Int J Pharm; 2023 Mar; 635():122768. PubMed ID: 36841369
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells.
Fan H; Zhu JH; Yao XQ
Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171
[TBL] [Abstract][Full Text] [Related]
10. Improving the Anticancer Efficacy of Laminin Receptor-Specific Therapeutic Ruthenium Nanoparticles (RuBB-Loaded EGCG-RuNPs) via ROS-Dependent Apoptosis in SMMC-7721 Cells.
Zhou Y; Yu Q; Qin X; Bhavsar D; Yang L; Chen Q; Zheng W; Chen L; Liu J
ACS Appl Mater Interfaces; 2016 Jun; 8(24):15000-12. PubMed ID: 26018505
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
12. Synergic effect between 5‑fluorouracil and celecoxib on hypoxic gastric cancer cells.
Zhang XQ; Sun XE; Liu WD; Feng YG; Zhang HM; Shi LH; Sun XN; Li YQ; Gao ZX
Mol Med Rep; 2015 Feb; 11(2):1160-6. PubMed ID: 25351347
[TBL] [Abstract][Full Text] [Related]
13. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression.
Findlay VJ; Wang C; Nogueira LM; Hurst K; Quirk D; Ethier SP; Staveley O'Carroll KF; Watson DK; Camp ER
Mol Cancer Ther; 2014 Nov; 13(11):2713-26. PubMed ID: 25249558
[TBL] [Abstract][Full Text] [Related]
14. Combined Therapeutic Effects of
Wu P; Zhu H; Zhuang Y; Sun X; Gu N
Int J Nanomedicine; 2020; 15():2777-2787. PubMed ID: 32368054
[TBL] [Abstract][Full Text] [Related]
15. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
[TBL] [Abstract][Full Text] [Related]
16. DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells.
Iwaizumi M; Tseng-Rogenski S; Carethers JM
Cancer Biol Ther; 2011 Oct; 12(8):756-64. PubMed ID: 21814034
[TBL] [Abstract][Full Text] [Related]
17. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
Zhao Y; Wang C; Goel A
Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
[TBL] [Abstract][Full Text] [Related]
18. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
Petty RD; Samuel LM; Murray GI; MacDonald G; O'Kelly T; Loudon M; Binnie N; Aly E; McKinlay A; Wang W; Gilbert F; Semple S; Collie-Duguid ES
BMC Cancer; 2009 Dec; 9():434. PubMed ID: 20003335
[TBL] [Abstract][Full Text] [Related]
19. Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy.
Phua LC; Mal M; Koh PK; Cheah PY; Chan EC; Ho HK
Cancer Chemother Pharmacol; 2013 Mar; 71(3):817-23. PubMed ID: 23271323
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
